When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase

Author： Brix Ditte Marie Bundgaard Clemmensen Knut Kristoffer Kallunki Tuula

Publisher： MDPI

E-ISSN： 2073-4409|3|1|53-78

ISSN： 2073-4409

Source： Cells, Vol.3, Iss.1, 2014-01, pp. : 53-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases

By Shih Andrew J. Telesco Shannon E. Radhakrishnan Ravi

Cancers, Vol. 3, Iss. 1, 2011-03 ,pp. : 1195-1231

MDPI

Access to resources Recommend Favorite

Molecular Mechanisms of Cardiotoxicity Induced by ErbB Receptor Inhibitor Cancer Therapeutics

By Hervent Anne-Sophie De Keulenaer Gilles W.

International Journal of Molecular Sciences, Vol. 13, Iss. 10, 2012-09 ,pp. : 12268-12286

MDPI

Access to resources Recommend Favorite

NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity

By Paletta-Silva Rafael Rocco-Machado Nathália Meyer-Fernandes José Roberto

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3683-3704

MDPI

Access to resources Recommend Favorite

Chimeric DNA Vaccines against ErbB2⁺ Carcinomas: From Mice to Humans

By Quaglino Elena Riccardo Federica Macagno Marco Bandini Silvio Cojoca Rodica Ercole Elisabetta Amici Augusto Cavallo Federica

Cancers, Vol. 3, Iss. 3, 2011-08 ,pp. : 3225-3241

MDPI

Access to resources Recommend Favorite

Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab

By Hughes Juliana Bentes Rødland Marianne Skeie Hasmann Max Madshus Inger Helene Stang Espen

Pharmaceuticals, Vol. 5, Iss. 7, 2012-06 ,pp. : 674-689

MDPI

Access to resources Recommend Favorite